Crossmark

Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses

Crossref DOI link: https://doi.org/10.1038/srep36658

Published Online: 2016-11-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tomusange, Khamis

Wijesundara, Danushka

Gummow, Jason

Wesselingh, Steve

Suhrbier, Andreas

Gowans, Eric J.

Grubor-Bauk, Branka
License Information

Text and Data Mining valid from 2016-11-17

Version of Record valid from 2016-11-17
More Information

Article History

Received: 4 July 2016

Accepted: 18 October 2016

First Online: 17 November 2016

Competing interests

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below